Veru Inc News

Veru to Present at the GLP-1 Based Therapeutics Summit

MIAMI, FL, May 02, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss,

GlobeNewswire08:30 ET

Veru to Report Fiscal 2024 Second Quarter Financial Results on May 8, 2024

MIAMI, FL, May 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ:VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high quality weight loss,

GlobeNewswireMay 1 08:30 ET

Express News | Veru Enrolls First Patients In Phase 2b Clinical Trial Of Enobosarm And Semaglutide Combination For Weight Loss

BenzingaApr 30 08:31 ET

Express News | Veru Inc: Topline Clinical Data Expected in Q4 Calendar Year 2024

ReutersApr 30 08:30 ET

Express News | Veru Enrolls First Patients in Phase 2B Clinical Trial of Enobosarm and Semaglutide Combination for High Quality Weight Loss

ReutersApr 30 08:30 ET

Veru to Present at the American Association of Clinical Endocrinology (AACE) 2024 Annual Meeting on May 9-11

MIAMI, FL, April 25, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late clinical stage biopharmaceutical company focused on developing innovative medicines for preserving muscle for high qual

GlobeNewswireApr 25 08:30 ET

Express News | Veru Inc: On April 23, Received Notification Letter From Nasdaq Confirming That Co Regained Compliance

ReutersApr 25 07:17 ET

Express News | Millennium Management LLC Reports 5.2% Passive Stake in Veru Inc as of April 18 - SEC Filing

Moomoo 24/7Apr 24 16:20 ET

LI, VERU and MRIN Among Pre-market Losers

Seeking AlphaApr 19 08:16 ET

Veru, EyePoint Pharmaceuticals, SINTX Technologies Among Healthcare Movers

Seeking AlphaApr 18 10:00 ET

Why Ultragenyx Pharmaceutical Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Monday's Mid-Day Session

Shares of Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) fell sharply during Monday's session after the company revealed new data from the Phase 1/2 study of GTX-102 for Angelman syndrome, a genetic d

BenzingaApr 15 14:11 ET

Express News | Veru : Oppenheimer Cuts Target Price to $5 From $7

Moomoo 24/7Apr 15 09:06 ET

Cisco To Rally Around 24%? Here Are 10 Top Analyst Forecasts For Monday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page. Wells Farg

BenzingaApr 15 08:39 ET

Express News | Oppenheimer Reiterates Outperform on Veru, Lowers Price Target to $5

Moomoo 24/7Apr 15 07:55 ET

Veru, Theravance Biopharma, Adial Pharmaceuticals Among Healthcare Movers

Seeking AlphaApr 12 10:00 ET

NKTR, VERU and EGIO Among Mid-day Movers

Seeking AlphaApr 11 12:55 ET

12 Consumer Staples Stocks Moving In Tuesday's After-Market Session

GainersFarmer Bros (NASDAQ:FARM) stock increased by 4.8% to $3.48 during Tuesday's after-market session. The company's market cap stands at $73.3 million. Pricesmart (NASDAQ:PSMT) stock moved upwards

BenzingaApr 9 16:31 ET

Veru Announces Date of 2024 Annual Meeting of Shareholders

--2023 Form 10-K/A and Q1 2024 Form 10-Q filed today-- --2024 Annual Meeting of Shareholders will be June 18, 2024 -- MIAMI, FL, April 01, 2024 (GLOBE NEWSWIRE) -- Veru Inc. (NASDAQ: VERU), a late c

GlobeNewswireApr 1 16:05 ET

Express News | Veru Shares Are Trading Higher After Raymond James Initiated Coverage on the Stock With an Outperform Rating and a Price Target of $3

Moomoo 24/7Mar 28 07:18 ET

Veru Initiated at Outperform by Raymond James

Veru Initiated at Outperform by Raymond James

Dow JonesMar 28 06:19 ET